Drug Patent Expirations in October 2010
Drug Patent Expirations in October 2010
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
|---|---|---|---|---|
| ORGARAN | Organon Usa Inc | danaparoid sodium | 5,164,377 | Oct 3, 2010 |
| MIRAPEX ER | Boehringer Ingelheim | pramipexole dihydrochloride | 4,886,812 | Oct 8, 2010 |
| MIRAPEX | Boehringer Ingelheim | pramipexole dihydrochloride | 4,886,812 | Oct 8, 2010 |
| CLIMARA PRO | Bayer Hlthcare | estradiol; levonorgestrel | 5,770,219 | Oct 12, 2010 |
| CLIMARA PRO | Bayer Hlthcare | estradiol; levonorgestrel | 5,252,334 | Oct 12, 2010 |
| MENTAX | Mylan | butenafine hydrochloride | 5,021,458 | Oct 18, 2010 |
| NUVIGIL | Cephalon | armodafinil | 4,927,855*PED | Oct 22, 2010 |
| CETROTIDE | Emd Serono | cetrorelix | 5,198,533 | Oct 24, 2010 |
| TRITEC | Glaxosmithkline | ranitidine bismuth citrate | 5,256,684 | Oct 26, 2010 |
| INVEGA SUSTENNA | Johnson And Johnson | paliperidone palmitate | 5,254,556 | Oct 27, 2010 |
| COMTAN | Orion | entacapone | 5,135,950 | Oct 31, 2010 |
| STALEVO 125 | Orion | carbidopa; entacapone; levodopa | 5,135,950 | Oct 31, 2010 |
| STALEVO 200 | Orion | carbidopa; entacapone; levodopa | 5,135,950 | Oct 31, 2010 |
| STALEVO 75 | Orion | carbidopa; entacapone; levodopa | 5,135,950 | Oct 31, 2010 |
| STALEVO 100 | Orion | carbidopa; entacapone; levodopa | 5,135,950 | Oct 31, 2010 |
| STALEVO 150 | Orion | carbidopa; entacapone; levodopa | 5,135,950 | Oct 31, 2010 |
| STALEVO 50 | Orion | carbidopa; entacapone; levodopa | 5,135,950 | Oct 31, 2010 |
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com
Yes, the “patent cliff” is fast upon us. What with so many biotech and similar companies now starting to face the dreaded moment, now is the time to start diversifying and shoring up their assets, if they haven’t done so already.
http://www.generalpatent.com/media/videos/patent-suits